Company intelligence / Profile preview

Assay.Works GmbH

Regensburg, Bavaria, Germanyassay.works ↗

Ownership: Private
Development stage: Other

Overview

Assay.Works is an active contract research organization specializing in the development and execution of predictive, scalable assays to quantify the bioactivity of novel chemical and biological entities. The company offers expertise in laboratory automation, informatics, cell line engineering, quantitative biology applications, high-throughput screening (HTS), and bioactivity assessments to pharmaceutical/biotech companies and academic organizations. There are no clinical results as it does not develop its own therapeutics.

Modalities: Small moleculesBiologics
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Assay.Works GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Assay.Works GmbH.

Explore the full profile